Comparison of safety and efficacy of triamcinolone 40 mg/ml with 10 mg/ml in chalazion

Araf Ali; Sheikh Sajjad

doi:10.18203/2320-6012.ijrms20232102

Authors

Araf Ali Department of Ophthalmology, SKIMS MCH, Bemina, J&K, India
Sheikh Sajjad Department of Ophthalmology, SKIMS MCH, Bemina, J&K, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20232102

Keywords:

Chalazion, Intralesional injection, Triamcinolone acetonide

Abstract

Background: Chalazion is a chronic sterile lipogranuloma caused by the obstruction and inflammation of the sebaceous glands of eyelids. A deep chalazion is caused by inflammation of the tarsal meibomian glands and a superficial chalazion by inflammation of Zeis glands. The main objective of the study was to compare the efficacy and safety of intralesional triamcinolone acetonide of 40mg/ml with 10mg/ml in patients with chalazion.

Methods: A comparative study was conducted at SKIMS MCH from January 2020 to August 2021. 68 patients were randomly divided into group A and group B. There were 32 eyes with chalazion in Group A and 36 eyes with chalazion in Group B. Group A was treated with triamcinolone 40mg/ml and group B with 20mg/ml. The follow-up was done at 1 week, 4 weeks, and 6 weeks.

Results: Of 32 eyes in Group A complete resolution was seen in 28 eyes (87.5%). In Group B out of 36 eyes, complete resolution was seen in 24 eyes (66.6%). Out of 68 patients, 30 were males (44.2%), and 38 were females (55.8%). Complications were marginally more in Group A, 3 patients had yellow white deposits on eyelids and 2 patients had raised intraocular pressure post steroid injection. In Group B, only 2 patients had yellow white deposits on eyelids. The size of the chalazion ranges between 5 to 12 mm. Complete resolution is considered when size reduction >85-90%.

Conclusions: It is concluded that intralesional triamcinolone acetonide of 40mg/ml is more effective than 10mg/ml. Although complications are slightly more in the previous than later, it is the rise in intraocular pressure which is of more concern. Thus proper pre-op workup and monitoring of intraocular pressure in the follow-up period are required.

Metrics

Metrics Loading ...

References

Jin KW, Shin Y J, Hyon JY. Effects of Chalazia on corneal astigmatism: Large-sized chalazia in the middle upper eyelids compress the cornea and induce corneal astigmatism. BMC Ophthalmol. 2017;17(1):36.

Fukuoka S, Arita R, Shirakawa R, Morishige N. Changes in meibomian gland morphology and ocular higher order aberration in eyes with chalazion. Clin Ophthalmol. 2017;11:1031-8

Patel S, Tohme N, Gorrin E, Kumar N, Goldhag, J B, Galor A. Prevalence and risk factors for chalazion in old veteran population. Br J Ophthalmol. 2022;106(9):1200-5.

Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. Clin Experiment Ophthalmol. 2007;35(8):706-12.

Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology.1980;87(3):218-21.

Foulks GN, Borchman D, Yappert M, Kamari S. Topical azithromycin and oral doxycycline therapy for meibomiam gland dysfunction: A comparative clinical and spectroscopic study. Cornea. 2013;32(1):44-53.

Ben Simon GJ, Huang L, Nakra T, Schwarcz RM, McCann JD, Goldberg RA. Intralesional triamcinolone acetonide for primary and recurrent chalazia: is it really effective? Ophthalmol. P2005;112(5):913-7.

Sommer A, Veraart J, Neumann M, Kessels A. Evaluation of the vasoconstrictive effects of topical steroids by laser- Doppler Perfusion-imaging. ActaDerm.-venereol. 1998;78(1):15-18.

Kumar J, Pathak AK, Verma A, Dwivedi S. Study of incidence and risk factors of chalazion in Bundelkhand region. IOSR J Dent Med Sci. 2017;16(5):5-8.

Rupali VK, Venukumar LR. Intralesional steroid in the treatment of chalazion. Inte Med J. 2014;1(1):22-4.

Eun JK, Sung Y, Byung JJ, Kyoo WL, Hong JM. The Effects of intralesional steroid injection for chalazion according to the concentrations of triamcinolone acetonide. J Korean Ophthalmol Soc 2007;54(3):396-400.

Watson AP, Austin DJ. Treatment of chalazions with injection of a steroid suspension. Brit J Ophthalmo. 1984;68(11):833-5.

Vasu N Naik, Shreeba B Vasu. Comparison of intralesional injection of triamcinolone 40 mg/ml and Triamcinolone 10 mg/ml in treatment of chalazion. IP Inter J Ocular Oncol Oculop. 2020;6(4):243-7.

Hoşal BM, Zilelioğlu G. Ocular complication of intralesional corticosteroid injection of a chalazion. Euro J Ophthalmol. 2003;13(9-10):798-9.